Local Bone Graft vs Iliac Crest Bone Graft

The comparison between local bone graft and iliac crest bone graft is one of the most important decisions in spinal fusion planning. Iliac crest bone graft has long been treated as the historical reference standard because it provides cells, proteins, and scaffold in one autologous graft source, but it also requires a separate harvest and introduces donor-site morbidity that local bone avoids.

​

Why iliac crest became the standard

Bone harvested from the iliac crest has traditionally been favored because it contains the three ingredients generally needed for fusion support: cells that can make bone, proteins that stimulate bone formation, and scaffold for bone growth. Review articles and patient-education material from AAOS continue to describe iliac crest autograft as a strong biologic source with a long track record in spine fusion.

That said, the strength of iliac crest graft is counterbalanced by the burden of harvesting it. Reported concerns include donor-site pain, infection, bleeding, hematoma, nerve injury, fracture, and cosmetic complaints, which is why many surgeons increasingly reserve iliac crest harvest for higher-risk fusion scenarios.

​

What local bone offers

Local bone graft is collected from bone already removed during the index spinal procedure, often from the lamina, spinous process, or other decompression bone. Its main advantages are practical and biologic at the same time: it is autologous, immediately available, and avoids a second incision.

The main limitation is quantity. AAOS notes that the amount of local bone available may be limited, and review literature also points out that local bone can contain fewer live cells and less cancellous architecture than iliac crest graft, depending on the source and preparation.

​

What comparative studies suggest local bone graft vs iliac crest bone graft

A systematic review comparing iliac crest bone graft with local autograft for lumbar fusion found that available studies generally showed no significant difference in fusion rates or patient-reported outcomes between the two groups. In the randomized trial included in that review, fusion rates were similar between local bone and iliac crest groups, and donor-site complications occurred only in the iliac crest cohort (6).

The same review also reported that donor-site pain, hematoma or seroma, and sensory loss were documented in iliac crest groups, while local autograft groups had no donor-site complications because no harvest site existed outside the primary exposure. This finding is clinically important because even when fusion outcomes appear similar, added morbidity can still affect recovery, satisfaction, and overall case efficiency.

​

Surgical trade-offs in practice

The practical question is not whether iliac crest graft is biologically potent, because it is. The more relevant question is whether that additional potency is necessary in a given case once the surgeon weighs donor-site morbidity, available local bone volume, the number of levels to be fused, fixation strategy, and patient risk factors such as smoking or prior nonunion.

For straightforward cases with adequate local bone, many surgeons may prefer to preserve and use the autologous bone already available in the field. For higher-risk cases or situations with limited local graft volume, iliac crest graft may still be selected or combined with other materials to strengthen the fusion strategy.

​

FAQ

Is iliac crest bone graft still the gold standard?

Historically, yes. Multiple sources still describe iliac crest autograft as the traditional reference standard, but its use has declined in many routine cases because of harvest-site morbidity and the availability of other graft strategies.

Does local bone fuse as well as iliac crest graft?

The best available comparative lumbar studies suggest similar fusion and clinical outcomes in selected cases. (6)

What is the biggest advantage of local bone?

It avoids a second harvest site while preserving autologous graft value already present in the surgical field.

Disclaimer

This article is informational and does not make claims about the performance, safety, or effectiveness of any specific medical device, graft product, or surgical technique. Clinical decisions must be based on surgeon judgment, patient‑specific factors, and current regulatory‑cleared indications. Nothing in this document should be interpreted as promoting a device, altering standard of care, or suggesting superiority of one graft option over another.

​

Reference list

1. Complications due to the use of BMP/INFUSE in spine surgery: The evidence continues to mount. Nancy E Epstein  https://pmc.ncbi.nlm.nih.gov/articles/PMC3717531/

2. Bone grafts in spine surgery (AAOS patient education)
   http://www.orthoinfo.org/treatment/bone-grafts-in-spine-surgery/

3. Bone grafting options for lumbar spine surgery: review of clinical efficacy and complications
   (Bone Morphogenetic Protein / grafting options review)
   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4365636/

4. Synthetic bone graft materials in spine fusion: current evidence and future trends
   http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092933/

5. Synthetic bone graft versus autograft or allograft for spinal fusion: a systematic review
   http://www.pubmed.ncbi.nlm.nih.gov/27231812/

6. Iliac crest bone graft versus local autograft or allograft for lumbar spinal fusion: a systematic review
   http://www.journals.sagepub.com/doi/10.1055/s-0035-1570749

7. RIM Medical Technologies – Knowledge Centre (Bone graft recovery / workflow content hub)
   http://www.rimmedtech.com/knowledge-centre